Active — Not RecruitingNot Applicable

Determinants of Bladder Cancer Recurrence Study (The DETER Study)

United States600 participantsStarted 2015-03

Plain-language summary

The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ≥18 years old AND * Histologically-confirmed non-muscle invasive bladder cancer (NMIBC) Exclusion Criteria: * Patients are ineligible for the study if they have/had: * Histologically-confirmed NMIBC diagnosed \>36 months prior to enrollment * Cystectomy prior to enrollment * Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures * Non English-speaking

What they're measuring

recurrence

Timeframe: 1 year

Trial details

NCT IDNCT02400944

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-03

View on ClinicalTrials.gov More Bladder Cancer trials